Results 81 to 90 of about 9,016 (186)

Editorial: Emerging heterocycles as bioactive compounds

Frontiers in Chemistry, 2023
Giovanna Li Petri, Giovanna Li Petri, Ralph Holl, Ralph Holl, Virginia Spanò, Marilia Barreca, Ignazio Sardo, Maria Valeria Raimondi   +7 more
doaj   +1 more source

Effect of alkyl chain length on the corrosion inhibition performance of 2-thioxo-2,3-dihydroquinazolin-4(1H)-one derivatives for carbon steel in HCl solution. [PDF]

Sci Rep
El-Maksoud SAA, Fathalla W, Saleh MS, El-Dossoki FI.   +3 more
europepmc   +1 more source

Synthesis and Biological Evaluation of New Quinazolin-4(3H)-One-Coumarin Hybrids Designed as Anticancer and Antibacterial Agents. [PDF]

Int J Mol Sci
Paramonova MP, Novikov MS, Sokhraneva VA, Zhivotova IS, Kezin VA, Zenov MA, Petrushanko IY, Novikova ON, Gorshenin AV, Velikorodnaya YI, Isakova EB, Shchekotikhin AE, Kochetkov SN, Matyugina ES, Khandazhinskaya AL.   +14 more
europepmc   +1 more source

7-Amino-2-(<i>N</i>,<i>N</i>-dimethylamino)quinazoline: a small, bright, easily synthesized scaffold for pH sensors. [PDF]

RSC Adv
Mahdaly M, Maki T, Osako R, Fujimaki Y, Suzuki Y.   +4 more
europepmc   +1 more source

In Silico Development of Novel Quinazoline-Based EGFR Inhibitors via 3D-QSAR, Docking, ADMET, and Molecular Dynamics. [PDF]

Int J Mol Sci
Moussaoui M, Baammi S, Baassi M, Kerraj S, Soufi H, Rachdi Y, Idrissi ME, Salah M, Belghiti ME, Daoud R, Belaaouad S.   +10 more
europepmc   +1 more source

Discovery of cytotoxic indolo[1,2-<i>c</i>]quinazoline derivatives through scaffold-based design. [PDF]

Beilstein J Org Chem
Khabarov DV, Litvinova VA, Dezhenkova LG, Kaluzhny DN, Tikhomirov AS, Shchekotikhin AE.   +5 more
europepmc   +1 more source

Discovery of novel quinazoline-sulfonamide derivatives with promising antidiabetic activity. [PDF]

Front Chem
Zayed MF, Muhammad Y, Alqurain AA, Banafa MAA, Omar AM.   +4 more
europepmc   +1 more source

Synthesis of 3-(arylamino) quinazoline-2,4(1H,3H)-dione derivatives via TBHP/I2: Molecular docking, MD simulation, DFT, and pharmacological evaluation as MTH1 inhibitors. [PDF]

PLoS One
Karim MG, Mehrdad M, Gheidari D, Gheidari NZ.   +3 more
europepmc   +1 more source

ZRMQ-22, a novel DYRK1A inhibitor, attenuates neuroinflammation and cognitive impairments in LPS-induced mice: a potential strategy for Alzheimer's disease. [PDF]

RSC Med Chem
Ren M, Chen H, Li Z, Zhuang J, Yang A, Li X, Li X, Wang X, Xu Z, Liu X, Song J, Jiang T, Xu Z, Gao X, Zhao Q.   +14 more
europepmc   +1 more source

Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease Inhibitor. [PDF]

J Med Chem
Papillon JPN, Yuan J, Hesse MJ, Zhang L, Robinson RI, Ware NF, Hornak V, Karki RG, Kirrane T, Garland K, Joseph S, Moquin SA, Lakshminarayana SB, Tandeske L, Dovala D, Knapp M, Ornelas E, Fuller D, Ho PI, Xie X, Vulic K, Skolnik SM, Gao J, Zambrowski M, Spiess M, Duca JS, Busby SA, Schirle M, Robinson M, Shi PY, Moser HE, Sarko C, Bradner JE, Diagana TT, Tallarico JA.   +34 more
europepmc   +1 more source